Postpartum thyroiditis risk factors: Difference between revisions
Usama Talib (talk | contribs) No edit summary |
Usama Talib (talk | contribs) No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 4: | Line 4: | ||
{{CMG}}; {{AE}} {{SKA}} | {{CMG}}; {{AE}} {{SKA}} | ||
==Overview== | ==Overview== | ||
The most potent risk factors in the development of [[Postpartum thyroiditis|postpartum thyroiditis PPT]] are [[Genetics|genetic]] abnormalities and subsequent pregnancies. Other risk factors for postpartum thyroiditis include [[smoking]], increase or decreased intake of [[ | The most potent risk factors in the development of [[Postpartum thyroiditis|postpartum thyroiditis (PPT)]] are [[Genetics|genetic]] abnormalities and subsequent pregnancies. Other risk factors for postpartum thyroiditis include [[smoking]], increase or decreased intake of [[iodine]], [[hepatitis C]], [[Radiation exposure|radiations]] and [[medications]]. | ||
==Risk Factors== | ==Risk Factors== | ||
Various factors associated with the development of PPT can be categorized into common and less common risk factors.<ref name="pmid25507668">{{cite journal| author=Argatska AB, Nonchev BI| title=Postpartum thyroiditis. | journal=Folia Med (Plovdiv) | year= 2014 | volume= 56 | issue= 3 | pages= 145-51 | pmid=25507668 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25507668 }}</ref> | |||
===Common Risk Factors=== | ===Common Risk Factors=== | ||
*Common risk factors in the development of [[Postpartum thyroiditis|PPT]] is [[Genetics|genetic]] abnormalities in: | *Common risk factors in the development of [[Postpartum thyroiditis|PPT]] is [[Genetics|genetic]] abnormalities in: | ||
Line 15: | Line 15: | ||
**HLA [[HLA-DR5|DR5]] haplotype | **HLA [[HLA-DR5|DR5]] haplotype | ||
* Subsequent pregnancies are also a common risk factor for postpartum thyroiditis. | * Subsequent pregnancies are also a common risk factor for the development of postpartum thyroiditis. | ||
===Less Common Risk Factors=== | ===Less Common Risk Factors=== | ||
*Less common risk factors in the development of postpartum thyroiditis ([[Postpartum thyroiditis|PPT]]) | *Less common risk factors in the development of postpartum thyroiditis ([[Postpartum thyroiditis|PPT]]) include: | ||
*#[[Smoking]] | *#[[Smoking]] | ||
*#Intake of [[Iodine]] | *#Intake of [[Iodine]] | ||
*#[[Radiation]] | *#[[Radiation]] | ||
*#Medications: | *#Medications: | ||
*#*[[Lithium]] | *#*[[Lithium]] | ||
*#*[[Amiodarone]] | |||
*#*[[Interferon alpha|Interferon alpha]] | |||
*#*[[Interleukin 2]] | |||
*#*Highly active [[HIV AIDS medical therapy|anti-retro-viral therapy]] | |||
*#[[Systemic lupus erythematosus|Systemic lupus erythromatosis]] | *#[[Systemic lupus erythematosus|Systemic lupus erythromatosis]] | ||
*#[[Multiple Sclerosis]] | *#[[Multiple Sclerosis]] |
Latest revision as of 14:59, 10 November 2017
Postpartum thyroiditis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Postpartum thyroiditis risk factors On the Web |
American Roentgen Ray Society Images of Postpartum thyroiditis risk factors |
Risk calculators and risk factors for Postpartum thyroiditis risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sunny Kumar MD [2]
Overview
The most potent risk factors in the development of postpartum thyroiditis (PPT) are genetic abnormalities and subsequent pregnancies. Other risk factors for postpartum thyroiditis include smoking, increase or decreased intake of iodine, hepatitis C, radiations and medications.
Risk Factors
Various factors associated with the development of PPT can be categorized into common and less common risk factors.[1]
Common Risk Factors
- Subsequent pregnancies are also a common risk factor for the development of postpartum thyroiditis.
Less Common Risk Factors
- Less common risk factors in the development of postpartum thyroiditis (PPT) include:
- Smoking
- Intake of Iodine
- Radiation
- Medications:
- Lithium
- Amiodarone
- Interferon alpha
- Interleukin 2
- Highly active anti-retro-viral therapy
- Systemic lupus erythromatosis
- Multiple Sclerosis
- Thyroid hormone resistance syndrome
References
- ↑ Argatska AB, Nonchev BI (2014). "Postpartum thyroiditis". Folia Med (Plovdiv). 56 (3): 145–51. PMID 25507668.